Clinical Research Directory
Browse clinical research sites, groups, and studies.
Tetracycline Treatment Tolerability Trial
Sponsor: Johns Hopkins University
Summary
Randomized, double-blind, placebo-controlled study (with a one-week washout period) where subjects receive either 3 months of tetracycline or 3 months of placebo. After the 3 month primary endpoint, in the follow-up period, patients will be assigned to the alternate treatment for 3 months with blind maintained.
Official title: T4 - Tetracycline Treatment Tolerability Trial A Pilot Study Examining the Feasibility and Tolerability of Tetracycline Therapy in Post-Treatment Lyme Disease (PTLD)
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2022-11-02
Completion Date
2027-12
Last Updated
2025-12-17
Healthy Volunteers
No
Conditions
Interventions
Tetracycline 500 Mg
500 mg three times daily
Placebo
Placebo for Tetracycline given same way as Tetracycline.
Locations (1)
Johns Hopkins Lyme Disease Research Center
Lutherville, Maryland, United States